Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04799847
Status:
RECRUITING
Last Update Posted:
2023-02-13
First Post:
2021-03-12
Brief Title:
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
Sponsor:
LintonPharm CoLtd
Organization:
LintonPharm CoLtd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-12
First Submit QC Date:
March 15 2021
Study First Post Date:
2021-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-09
Last Update Post Date:
2023-02-13
Last Update Post Date Type:
ACTUAL